DSM and Cargill established the Joint Venture Avansya


Royal DSM and Cargill established Avansya V.O.F. The 50:50 joint venture is a partnership between the two companies. Both parties announced their intention to establish this joint venture on 8 November 2018 subject to regulatory approvals. Avansya will produce zero-calorie, great-tasting sweeteners through fermentation and will be headquartered at the Biotech Campus Delft (Netherlands).

As food and beverage producers look to significantly reduce calories in their offerings to consumers, they are in need of non-artificial, zero-calorie, great-tasting sweetener options. Avansya will produce highly sought-after, sweet-tasting molecules, such as steviol glycosides Reb M and Reb D through fermentation, giving food and beverage manufacturers an even more scalable, sustainable and low cost-in-use solution than if these same molecules were extracted from the stevia leaf.

Avansya’s sweeteners will be produced at a fermentation facility at the Cargill site in Blair and Avansya will market its sweeteners under the EverSweet™ brand.

Oscar Goddijn will serve as CEO for Avansya and Andrew Ohmes as VP Marketing & Sales. Biotechnologist Goddijn has been with DSM for more than 16 years, most recently as Vice President Stevia & Sugar Reduction Products. Ohmes continues to be globally responsible for high intensity sweeteners at Cargill, where he has built his career since 2000, in addition to his VP Marketing & Sales role for Avansya.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.